TY - JOUR
T1 - Activation dynamics of a water-soluble human mu-opioid receptor
AU - Agyemang, Eugene
AU - Van Wirt, Raegan
AU - Walls, Calixte
AU - Joseph, Thomas T.
AU - Tiruvadi-Krishnan, Sriram
AU - Grothusen, John
AU - Zhang, Qiu
AU - Hicks, Alan
AU - Leite, Wellington
AU - Osti, Naresh C.
AU - Mamontov, Eugene
AU - O’Neill, Hugh M.
AU - Liu, Renyu
AU - Lamichhane, Rajan
N1 - Publisher Copyright:
© 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology. This is an open access article under the CC BY license. http://creativecommons.org/licenses/by/4.0/
PY - 2026/5
Y1 - 2026/5
N2 - The mu-opioid receptor (MOR), a class A G protein-coupled receptor mediates opioid analgesia and remains a central target for pain therapeutics. While crystal structures of MOR exist, they provide limited insight into the receptor’s dynamic conformational landscape underlying function. Here, we engineered a thermostable water-soluble MOR variant (wsMOR) that retains native-like ligand-binding and activation dynamics. This variant enables high-yield production and detailed solution-phase structural studies that are challenging with membrane-embedded MOR, providing a valuable tool for studying receptor activation and aqueous-phase drug screening. Using a combined computational and experimental approach, we performed long-timescale all-atom molecular dynamics simulations together with neutron scattering and single-molecule FRET, revealing a structurally stable receptor with a diverse ensemble of conformations at different temporal resolutions. In the ligand-free state, wsMOR displayed high conformational flexibility, which decreased upon agonist binding, particularly in transmembrane helix 6, a hallmark of G protein-coupled receptor activation. Positive allosteric modulation and G protein binding further stabilized active-like states. These findings highlight wsMOR’s conformational plasticity across picosecond to millisecond timescales and provide a foundation for structure-guided development of next-generation opioid ligands with improved efficacy and safety.
AB - The mu-opioid receptor (MOR), a class A G protein-coupled receptor mediates opioid analgesia and remains a central target for pain therapeutics. While crystal structures of MOR exist, they provide limited insight into the receptor’s dynamic conformational landscape underlying function. Here, we engineered a thermostable water-soluble MOR variant (wsMOR) that retains native-like ligand-binding and activation dynamics. This variant enables high-yield production and detailed solution-phase structural studies that are challenging with membrane-embedded MOR, providing a valuable tool for studying receptor activation and aqueous-phase drug screening. Using a combined computational and experimental approach, we performed long-timescale all-atom molecular dynamics simulations together with neutron scattering and single-molecule FRET, revealing a structurally stable receptor with a diverse ensemble of conformations at different temporal resolutions. In the ligand-free state, wsMOR displayed high conformational flexibility, which decreased upon agonist binding, particularly in transmembrane helix 6, a hallmark of G protein-coupled receptor activation. Positive allosteric modulation and G protein binding further stabilized active-like states. These findings highlight wsMOR’s conformational plasticity across picosecond to millisecond timescales and provide a foundation for structure-guided development of next-generation opioid ligands with improved efficacy and safety.
KW - allosteric modulation
KW - g protein
KW - G protein-coupled receptor (GPCR)
KW - mu-opioid receptor
KW - neutron scattering
KW - single-molecule FRET (smFRET)
KW - structural dynamics
UR - https://www.scopus.com/pages/publications/105036118947
U2 - 10.1016/j.jbc.2026.111393
DO - 10.1016/j.jbc.2026.111393
M3 - Article
C2 - 41866033
AN - SCOPUS:105036118947
SN - 0021-9258
VL - 302
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 5
M1 - 111393
ER -